1 Ocak 2017 Dergi makalesi Açık Erişim

Yoshimatsu, Gumpei; Kunnathodi, Faisal; Saravanan, Prathab Balaji; Shahbazov, Rauf; Chang, Charles; Darden, Carly M.; Zurawski, Sandra; Boyuk, Gulbahar; Kanak, Mazhar A.; Levy, Marlon F.; Naziruddin, Bashoo; Lawrence, Michael C.

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kunnathodi, Faisal</subfield>
    <subfield code="u">Baylor Res Inst, Islet Cell Lab, Dallas, TX 75226 USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Saravanan, Prathab Balaji</subfield>
    <subfield code="u">Baylor Res Inst, Islet Cell Lab, Dallas, TX 75226 USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Shahbazov, Rauf</subfield>
    <subfield code="u">Baylor Res Inst, Islet Cell Lab, Dallas, TX 75226 USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Chang, Charles</subfield>
    <subfield code="u">Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Darden, Carly M.</subfield>
    <subfield code="u">Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Zurawski, Sandra</subfield>
    <subfield code="u">Baylor Inst Immunol Res, Dallas, TX USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Boyuk, Gulbahar</subfield>
    <subfield code="u">Diskapi Yildirim Beyazit Training &amp; Res Hosp, Dept Endocrinol &amp; Metab, Adacell Med Res Ctr, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kanak, Mazhar A.</subfield>
    <subfield code="u">Virginia Commonwealth Univ, Sch Med, Dept Surg, Richmond, VA USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Levy, Marlon F.</subfield>
    <subfield code="u">Virginia Commonwealth Univ, Sch Med, Dept Surg, Richmond, VA USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Naziruddin, Bashoo</subfield>
    <subfield code="u">Baylor Univ, Med Ctr, Annette C &amp; Harold C Simmons Transplant Inst, Dallas, TX USA</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Lawrence, Michael C.</subfield>
    <subfield code="u">Baylor Res Inst, Islet Cell Lab, Dallas, TX 75226 USA</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">DIABETES</subfield>
    <subfield code="v">66</subfield>
    <subfield code="n">11</subfield>
    <subfield code="c">2857-2867</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.2337/db17-0578</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Pancreatic beta-Cell-Derived IP-10/CXCL10 Isletokine Mediates Early Loss of Graft Function in Islet Cell Transplantation</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Yoshimatsu, Gumpei</subfield>
    <subfield code="u">Baylor Res Inst, Islet Cell Lab, Dallas, TX 75226 USA</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:111010</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2017-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/111010/files/bib-6b561e04-2ca2-4d07-9696-345aa01a641b.txt</subfield>
    <subfield code="z">md5:cc4f87a7494ebc368d8aa5eddcee15d6</subfield>
    <subfield code="s">319</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20210420141506.0</controlfield>
  <controlfield tag="001">111010</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Pancreatic islets produce and secrete cytokines and chemokines in response to inflammatory and metabolic stress. The physiological role of these isletokines in health and disease is largely unknown. We observed that islets release multiple inflammatory mediators in patients undergoing islet transplants within hours of infusion. The proinflammatory cytokine interferon-gamma-induced protein 10 (IP-10/CXCL10) was among the highest released, and high levels correlated with poor islet transplant outcomes. Transgenic mouse studies confirmed that donor islet-specific expression of IP-10 contributed to islet inflammation and loss of beta-cell function in islet grafts. The effects of islet-derived IP-10 could be blocked by treatment of donor islets and recipient mice with anti-IP-10 neutralizing monoclonal antibody. In vitro studies showed induction of the IP-10 gene was mediated by calcineurin-dependent NFAT signaling in pancreatic beta-cells in response to oxidative or inflammatory stress. Sustained association of NFAT and p300 histone acetyltransferase with the IP-10 gene required p38 and c-Jun N-terminal kinase mitogen-activated protein kinase (MAPK) activity, which differentially regulated IP-10 expression and subsequent protein release. Overall, these findings elucidate an NFAT-MAPK signaling paradigm for induction of isletokine expression in beta-cells and reveal IP-10 as a primary therapeutic target to prevent beta-cell-induced inflammatory loss of graft function after islet cell transplantation.</subfield>
  </datafield>
</record>